BioMarin Q1 2026 slides: revenue beats offset by margin pressure
AI Summary
BioMarin Pharmaceuticals reported its Q1 2026 results, showing a revenue beat; however, it was offset by margin pressure affecting overall performance. The company continues to navigate a competitive market environment while focusing on sustainable growth.